Paralysis after treatment for thyrotoxicosis.

Por Janssen, H. L., Geelhoed-Duijvestijn, P. H., de Weerd, A. W.
Publicado em 1997

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep).

Por Janssen, H. L., Brouwer, J. T., Nevens, F., Sanchez-Tapias, J. M., Craxi, A., Hadziyannis, S.
Publicado em 1993

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy

Por Flink, H J, Sprengers, D, Hansen, B E, van Zonneveld, M, de Man, R A, Schalm, S W, Janssen, H L A
Publicado em 2005

Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.

Por Janssen, H L, Berk, L, Schalm, S W, Heijtink, R A, Hess, G, Rossol, S, Meyer zum Buschenfelde, K H, Chamuleau, R A, Jansen, P L, Reesink, H W
Publicado em 1992

Liver failure after delivery

Por de Groot, C J M, van Goor, G M, Stolk, M F, Metselaar, H J, Janssen, H L A, Kazemier, G, Zondervan, P E, Wanless, I R
Publicado em 2005

Relapse after treatment with peginterferon α‐2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B

Por Flink, H J, Buster, E H C J, Merican, I, Nevens, F, Kitis, G, Cianciara, J, de Vries, R A, Hansen, B E, Schalm, S W, Janssen, H L A
Publicado em 2007

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotr...

Por van Nunen, A B, Hansen, B E, Suh, D J, Löhr, H F, Chemello, L, Fontaine, H, Heathcote, J, Song, B C, Janssen, H L A, de Man, R A, Schalm, S W
Publicado em 2003